June 2002

1
June 2002
EMS Outcomes Project And National EMS Research
Agenda
Cindy Doyle, RN, Program Director Dan Kavanaugh,
LCSW-C, Project Officer
2
Recommendation 3

• The federal government should increase its
  commitment and support of EMS research
• Joint federal program announcements to provide
  opportunities for conducting EMS research
• Increase the number of fully federally funded
  clinical trials in the EMS setting by 25 each
  year for five years beginning in FY03
• from the National EMS Research Agenda

3
EMSC-NDDP
4
EMSC Research
Multi-Agency Research Announcement

• Maternal and Child Health Bureau, HRSA
• Agency for Healthcare Research and Quality, AHRQ
• National Institute for Occupational Safety and
  Health, CDC
• National Heart, Lung, and Blood Institute, NIH
• National Institute of Child Health and Human
  Development, NIH
• National Institute on Drug Abuse, NIH
• National Institute of Mental Health, NIH
• National Institute of Nursing Research, NIH

5
Interagency Agreements

• NHTSA
• Indian Health Service
• CDC/National Center for Health Statistics

6
EMSC-NDDP
National EMSC Data Analysis (NEDARC) (Interim)
Coordinating Data Center
7
EMSC-NDDP
8
Central Data Management and Coordinating Data
Center

• To provide PECARN regional nodes with
• Data collection and management
• Data analysis guidelines
• Serve as a central repository for PECARN
  generated data
• Serve as a central resource network data base for
  the public

9
MCH Research Grants

• Post-Traumatic Stress Disorder after Pediatric
  Traffic-Related Injury
• Flaura Winston, MD, Ph.D. Childrens Hospital of
  Philadelphia
• Pediatric Phase (Prehospital Arrest Survival
  Evaluation)
• George Foltin, MD New York University Medical
  Center

10
Advocacy

• TUCSON, Ariz., Feb. 27, 2001 - Entertainer Jerry
  Lewis told a Senate subcommittee today that a
  100 million annual increase in government
  funding is needed to get to the next level in
  muscular dystrophy research

11
Advocacy
Sen. Charles Schumer (D-NY) met with more than 40
lymphoma, myeloma, and leukemia
constituent-advocates and pledged his continued
support to fund the research needed to eradicate
these diseases.
12
Advocacy